Sigma Planning Corp’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.07M | Buy |
210,735
+39,162
| +23% | +$1.02M | 0.13% | 171 |
|
|
2026
Q1 | $4.82M | Buy |
171,573
+5,500
| +3% | +$146K | 0.13% | 161 |
|
|
2025
Q4 | $4.14M | Buy |
166,073
+9,868
| +6% | +$249K | 0.11% | 181 |
|
|
2025
Q3 | $3.98M | Sell |
156,205
-9,720
| -6% | -$240K | 0.11% | 186 |
|
|
2025
Q2 | $4.02M | Sell |
165,925
-14,167
| -8% | -$330K | 0.12% | 174 |
|
|
2025
Q1 | $4.56M | Buy |
180,092
+28,562
| +19% | +$747K | 0.15% | 141 |
|
|
2024
Q4 | $4.02M | Sell |
151,530
-16,023
| -10% | -$435K | 0.13% | 166 |
|
|
2024
Q3 | $4.85M | Buy |
167,553
+165
| +0.1% | +$4.81K | 0.15% | 131 |
|
|
2024
Q2 | $4.68M | Buy |
167,388
+1,878
| +1% | +$51.7K | 0.15% | 132 |
|
|
2024
Q1 | $4.59M | Buy |
165,510
+83,668
| +102% | +$2.32M | 0.14% | 141 |
|
|
2023
Q4 | $2.36M | Sell |
81,842
-90,871
| -53% | -$2.75M | 0.18% | 105 |
|
|
2023
Q3 | $5.73M | Buy |
172,713
+7,558
| +5% | +$267K | 0.21% | 87 |
|
|
2023
Q2 | $6.06M | Sell |
165,155
-29,477
| -15% | -$1.15M | 0.22% | 89 |
|
|
2023
Q1 | $7.94M | Sell |
194,632
-24,759
| -11% | -$1.07M | 0.26% | 79 |
|
|
2022
Q4 | $11.2M | Sell |
219,391
-2,134
| -1% | -$102K | 0.4% | 45 |
|
|
2022
Q3 | $9.69M | Sell |
221,525
-2,180
| -1% | -$106K | 0.37% | 50 |
|
|
2022
Q2 | $11.7M | Sell |
223,705
-3,753
| -2% | -$191K | 0.41% | 42 |
|
|
2022
Q1 | $11.8M | Sell |
227,458
-27,738
| -11% | -$1.44M | 0.35% | 50 |
|
|
2021
Q4 | $15.1M | Sell |
255,196
-3,991
| -2% | -$198K | 0.42% | 38 |
|
|
2021
Q3 | $11.1M | Buy |
259,187
+10,907
| +4% | +$483K | 0.34% | 51 |
|
|
2021
Q2 | $9.72M | Sell |
248,280
-2,240
| -0.9% | -$87.1K | 0.29% | 64 |
|
|
2021
Q1 | $9.08M | Sell |
250,520
-422
| -0.2% | -$15K | 0.29% | 68 |
|
|
2020
Q4 | $9.24M | Buy |
250,942
+20,151
| +9% | +$739K | 0.31% | 66 |
|
|
2020
Q3 | $8.04M | Buy |
230,791
+29,075
| +14% | +$1.02M | 0.32% | 59 |
|
|
2020
Q2 | $6.26M | Buy |
201,716
+18,871
| +10% | +$641K | 0.27% | 71 |
|
|
2020
Q1 | $5.66M | Buy |
182,845
+6,582
| +4% | +$224K | 0.34% | 54 |
|
|
2019
Q4 | $6.55M | Buy |
176,263
+8,757
| +5% | +$312K | 0.28% | 68 |
|
|
2019
Q3 | $5.71M | Buy |
167,506
+21,534
| +15% | +$783K | 0.27% | 69 |
|
|
2019
Q2 | $6M | Sell |
145,972
-2,129
| -1% | -$84.5K | 0.31% | 64 |
|
|
2019
Q1 | $5.97M | Buy |
148,101
+3,257
| +2% | +$130K | 0.34% | 61 |
|
|
2018
Q4 | $6M | Sell |
144,844
-4,630
| -3% | -$192K | 0.44% | 51 |
|
|
2018
Q3 | $6.25M | Sell |
149,474
-279
| -0.2% | -$10.7K | 0.37% | 53 |
|
|
2018
Q2 | $5.16M | Buy |
149,753
+5,740
| +4% | +$196K | 0.35% | 61 |
|
|
2018
Q1 | $4.85M | Buy |
144,013
+5,081
| +4% | +$175K | 0.35% | 61 |
|
|
2017
Q4 | $4.77M | Buy |
138,932
+3,712
| +3% | +$127K | 0.37% | 54 |
|
|
2017
Q3 | $4.58M | Sell |
135,220
-5,969
| -4% | -$192K | 0.38% | 51 |
|
|
2017
Q2 | $4.5M | Sell |
141,189
-23,528
| -14% | -$742K | 0.42% | 49 |
|
|
2017
Q1 | $5.35M | Buy |
164,717
+36,064
| +28% | +$1.14M | 0.52% | 40 |
|
|
2016
Q4 | $3.96M | Buy |
128,653
+17,527
| +16% | +$535K | 0.43% | 46 |
|
|
2016
Q3 | $3.57M | Buy |
111,126
+9,939
| +10% | +$332K | 0.42% | 48 |
|
|
2016
Q2 | $3.38M | Buy |
101,187
+7,904
| +8% | +$252K | 0.44% | 44 |
|
|
2016
Q1 | $2.62M | Buy |
93,283
+8,402
| +10% | +$240K | 0.36% | 59 |
|
|
2015
Q4 | $2.6M | Buy |
84,881
+2,446
| +3% | +$76.9K | 0.36% | 55 |
|
|
2015
Q3 | $2.46M | Buy |
82,435
+11,316
| +16% | +$363K | 0.39% | 55 |
|
|
2015
Q2 | $2.26M | Sell |
71,119
-3,631
| -5% | -$118K | 0.31% | 77 |
|
|
2015
Q1 | $2.47M | Sell |
74,750
-6,089
| -8% | -$194K | 0.33% | 62 |
|
|
2014
Q4 | $2.39M | Buy |
+80,839
| New | +$2.32M | 0.32% | 79 |
|
Other funds holding PFE
Sigma Planning Corp's PFE Position: Q2 2026 in Review
Sigma Planning Corp increased its Pfizer (PFE) stake by 23% in Q2 2026, buying an estimated $1.02M and bringing the position to 210,735 shares worth $5.07M. The position accounts for 0.13% of the portfolio, ranked #171.
Sigma Planning Corp first reported a position in PFE in Q4 2014 and has held it in 47 quarters since. The position peaked at $15.1M in Q4 2021. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Sigma Planning Corp held 210,735 shares of Pfizer worth $5.07M as of Q2 2026.
- Sigma Planning Corp bought 39,162 Pfizer shares in Q2 2026, an estimated $1.02M.
- Pfizer made up 0.13% of Sigma Planning Corp's portfolio in Q2 2026, its #171 holding.
- Sigma Planning Corp first reported a position in Pfizer in Q4 2014 and has held it in 47 quarters since.
- Sigma Planning Corp's Pfizer position peaked at $15.1M in Q4 2021.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Sigma Planning Corp's 13F filing for Q2 2026, filed 7 Aug 2026.